Opus Genetics (IRD) Other Working Capital Changes (2019 - 2026)
Opus Genetics has reported Other Working Capital Changes over the past 13 years, most recently at $2.1 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 147.28% to $2.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Mar 2026, up 1207.39% year-over-year, with the annual reading at $1.3 million for FY2025, 300.79% up from the prior year.
- Other Working Capital Changes was $2.1 million for Q1 2026 at Opus Genetics, up from $973000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.1 million in Q1 2026 and troughed at -$685000.0 in Q3 2024.
- The 5-year median for Other Working Capital Changes is $82.0 (2022), against an average of $171651.9.
- Year-over-year, Other Working Capital Changes crashed 434246.34% in 2023 and then skyrocketed 2602.78% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $848000.0 in 2022, then fell by 27.48% to $615000.0 in 2023, then crashed by 94.15% to $36000.0 in 2024, then skyrocketed by 2602.78% to $973000.0 in 2025, then skyrocketed by 119.84% to $2.1 million in 2026.
- Per Business Quant, the three most recent readings for IRD's Other Working Capital Changes are $2.1 million (Q1 2026), $973000.0 (Q4 2025), and -$618000.0 (Q3 2025).